• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吞咽钡剂造影检查在预测老年喉咽反流病尤其是非糜烂性反流病患者对雷贝拉唑反应中的价值。

Value of barium swallow studies in predicting the response to rabeprazole in elderly patients with laryngopharyngeal reflux disease and nonerosive reflux disease in particular.

作者信息

Kimura Yurika, Sugiura Mutsumi, Kato Tomofumi, Makino Nao, Ohmae Yukio, Kishimoto Seiji

机构信息

Department of Otolaryngology, Tokyo Metropolitan Geriatric Hospital, 35-2 Sakaecho, Itabashi-ku, Tokyo-to, Japan 173-0015.

出版信息

Ann Otol Rhinol Laryngol. 2010 Sep;119(9):631-5. doi: 10.1177/000348941011900911.

DOI:10.1177/000348941011900911
PMID:21033032
Abstract

OBJECTIVES

Laryngopharyngeal reflux disease (LPRD) is an important cause of throat discomfort in the elderly. Our objective was to investigate the usefulness of barium swallow studies for the diagnosis of LPRD.

METHODS

The subjects were 59 patients at least 60 years of age with LPRD suspected on laryngoscopic findings. We evaluated esophageal clearance using a barium swallow study and the upper gastrointestinal tract endoscopic findings of gastroesophageal reflux disease according to the revised Los Angeles classification, and correlated these findings with the effect of rabeprazole, a proton pump inhibitor.

RESULTS

Among subjects with positive reflux findings in the esophageal phase of the barium swallow, rabeprazole was significantly effective (p = 0.0025). To identify nonerosive reflux disease, we analyzed the 50 cases with a negative Los Angeles classification of upper gastrointestinal tract endoscopic findings. Rabeprazole was again significantly effective in patients with positive findings for esophageal reflux (p = 0.0025).

CONCLUSIONS

Among elderly patients with suspected LPRD, there was a positive correlation between impaired esophageal clearance on the barium swallow study and the effectiveness of rabeprazole. The barium swallow study could be a screening test for LPRD in elderly patients with throat discomfort.

摘要

目的

喉咽反流病(LPRD)是老年人咽喉不适的重要原因。我们的目的是研究吞钡检查对LPRD诊断的实用性。

方法

研究对象为59例年龄至少60岁、喉镜检查怀疑患有LPRD的患者。我们通过吞钡检查评估食管清除功能,并根据修订的洛杉矶分类法评估胃食管反流病的上消化道内镜检查结果,将这些结果与质子泵抑制剂雷贝拉唑的疗效相关联。

结果

在吞钡食管期反流结果为阳性的受试者中,雷贝拉唑具有显著疗效(p = 0.0025)。为了识别非糜烂性反流病,我们分析了50例上消化道内镜检查洛杉矶分类为阴性的病例。雷贝拉唑对食管反流结果为阳性的患者同样具有显著疗效(p = 0.0025)。

结论

在疑似LPRD的老年患者中,吞钡检查显示的食管清除功能受损与雷贝拉唑的疗效之间存在正相关。吞钡检查可为咽喉不适的老年患者筛查LPRD。

相似文献

1
Value of barium swallow studies in predicting the response to rabeprazole in elderly patients with laryngopharyngeal reflux disease and nonerosive reflux disease in particular.吞咽钡剂造影检查在预测老年喉咽反流病尤其是非糜烂性反流病患者对雷贝拉唑反应中的价值。
Ann Otol Rhinol Laryngol. 2010 Sep;119(9):631-5. doi: 10.1177/000348941011900911.
2
Prospective, observational study using rabeprazole in 455 patients with laryngopharyngeal reflux disease.前瞻性、观察性研究,使用雷贝拉唑治疗 455 例咽喉反流病患者。
Eur Arch Otorhinolaryngol. 2011 Jun;268(6):863-9. doi: 10.1007/s00405-010-1475-9. Epub 2011 Jan 11.
3
[Laryngopharyngeal reflux disease (LPRD) in children].[儿童喉咽反流疾病(LPRD)]
Laryngorhinootologie. 2017 Jul;96(7):485-496. doi: 10.1055/s-0043-109188. Epub 2017 Aug 2.
4
Esophageal motor dysfunction plays a key role in GERD with globus sensation--analysis of factors promoting resistance to PPI therapy.食管运动功能障碍在伴有咽部异物感的胃食管反流病中起关键作用——促进对质子泵抑制剂治疗产生抵抗的因素分析
Scand J Gastroenterol. 2012 Sep;47(8-9):893-9. doi: 10.3109/00365521.2012.685756. Epub 2012 May 18.
5
Rabeprazole is effective in treating laryngopharyngeal reflux in a randomized placebo-controlled trial.雷贝拉唑在一项随机安慰剂对照试验中治疗咽反流有效。
Clin Gastroenterol Hepatol. 2010 Sep;8(9):770-6. doi: 10.1016/j.cgh.2010.03.009. Epub 2010 Mar 18.
6
Comparison of patients of chronic laryngitis with and without troublesome reflux symptoms.比较有和无烦人的反流症状的慢性喉炎患者。
J Gastroenterol Hepatol. 2012 Mar;27(3):579-85. doi: 10.1111/j.1440-1746.2011.06868.x.
7
An Open Label, Prospective, Single Centre Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Rabeprazole (Enteric-Coated, EC) 20 mg + Domperidone (Sustained Release, SR) 30 mg Capsule in Treatment of Patients with Laryngopharyngeal Reflux Disease.一项开放标签、前瞻性、单中心研究,旨在评估雷贝拉唑(肠溶包衣,EC)20毫克+多潘立酮(缓释,SR)30毫克固定剂量组合胶囊治疗喉咽反流病患者的疗效和安全性。
J Assoc Physicians India. 2015 Jul;63(7):27-32.
8
Treatment of clinically diagnosed laryngopharyngeal reflux disease.临床诊断的喉咽反流病的治疗。
Arch Otolaryngol Head Neck Surg. 2010 Nov;136(11):1089-92. doi: 10.1001/archoto.2010.165. Epub 2010 Sep 20.
9
Effects of proton pump inhibitors in patients with laryngopharyngeal reflux disease.质子泵抑制剂对喉咽反流病患者的影响。
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1580-2. doi: 10.5754/hge09607. Epub 2011 Jul 15.
10
Influence of cytochrome P450 2C19 genetic polymorphism and dosage of rabeprazole on accuracy of proton-pump inhibitor testing in Chinese patients with gastroesophageal reflux disease.细胞色素P450 2C19基因多态性及雷贝拉唑剂量对中国胃食管反流病患者质子泵抑制剂检测准确性的影响
J Gastroenterol Hepatol. 2007 Aug;22(8):1286-92. doi: 10.1111/j.1440-1746.2007.04942.x. Epub 2007 Jun 7.

引用本文的文献

1
Dynamic swallowing study for globus patients.对癔球症患者进行动态吞咽研究。
World J Otorhinolaryngol Head Neck Surg. 2016 Dec 15;2(4):198-202. doi: 10.1016/j.wjorl.2016.07.002. eCollection 2016 Dec.